Psychiatry and Neurology, Neurology · Irvine, CA
NPI
1740454586
Since 2008
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
15775 Laguna Canyon Rd Ste 190
Irvine, CA, 92618
Phone (714) 602-9891
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
154,016 services
Medicare patients, 2024
1,354
Average age 77
Drug cost, 2024
$5.6M
10,107 prescriptions
Company payments, 2025
$376K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Sandeep K Thakkar was code J0585 (injection, onabotulinumtoxina, 1 unit), 120,750 times for 274 patients. In total Sandeep K Thakkar billed 154,016 services in 27 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-04-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 120,750 | 274 | $4.98 | $601K |
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 20,760 | 64 | $4.09 | $85K |
| J0587 Injection, rimabotulinumtoxinb, 100 units | Office | 2,350 | 19 | $10.01 | $24K |
| 99215 Office E&M - Established | Office | 2,123 | 763 | $142.19 | $302K |
| 99215 Office E&M - Established | Facility | 1,020 | 423 | $110.75 | $113K |
| 64644 Musculoskeletal | Office | 352 | 132 | $142.71 | $50K |
| 64611 Musculoskeletal | Office | 314 | 115 | $93.67 | $29K |
| 64616 Musculoskeletal | Office | 294 | 111 | $150.62 | $44K |
| 99214 Office E&M - Established | Office | 268 | 186 | $102.33 | $27K |
| 64643 Musculoskeletal | Office | 224 | 84 | $79.17 | $18K |
| 99205 Office E&M - New | Office | 219 | 219 | $177.71 | $39K |
| 64642 Musculoskeletal | Office | 209 | 82 | $119.67 | $25K |
| 99205 Office E&M - New | Facility | 195 | 195 | $145.32 | $28K |
| 64611 Musculoskeletal | Facility | 190 | 73 | $89.06 | $17K |
| 95984 Electrical Nerve Conductivity | Office | 169 | 41 | $35.65 | $6,026 |
By year: 2022 $1.2M for 109,493 services; 2023 $1.4M for 138,762 services; 2024 $1.5M for 154,016 services.
Medicare prescription drug claims, 2024
In 2024, the drug Sandeep K Thakkar prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 2,344 prescriptions and refills. In total Sandeep K Thakkar wrote 10,107 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 2,344 | 6,183 | 743 | $97K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 695 | 1,698 | 211 | $39K |
| Rytary Carbidopa/Levodopa | 681 | 1,431 | 173 | $556K |
| Memantine Hcl Generic | 676 | 1,627 | 205 | $20K |
| Donepezil Hcl Generic | 564 | 1,429 | 191 | $6,636 |
| Rasagiline Mesylate Generic | 528 | 1,267 | 154 | $125K |
| Gabapentin Generic | 382 | 907 | 130 | $6,037 |
| Nuplazid Pimavanserin Tartrate | 341 | 403 | 46 | $2.0M |
| Escitalopram Oxalate Generic | 289 | 733 | 84 | $3,187 |
| Primidone Generic | 253 | 679 | 79 | $7,360 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 235 | 541 | 70 | $4,693 |
| Pramipexole Er Pramipexole Di-Hcl | 184 | 426 | 44 | $70K |
| Mirtazapine Generic | 175 | 418 | 57 | $6,718 |
| Ongentys Opicapone | 173 | 256 | 35 | $167K |
| Propranolol Hcl Generic | 154 | 392 | 55 | $2,391 |
Brand drugs: 2,274 claims; generic drugs: 7,833 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Sandeep K Thakkar $376K ($370K in general payments such as food, travel and fees and $5,635 for research) from 17 companies. The largest payer was Abbvie Inc. with $107K.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 145 | $107K |
| Neurocrine BioSciences, Inc. NBIX | 80 | $91K |
| Medtronic, Inc. MDT | 75 | $65K |
| Amneal Pharmaceuticals LLC AMRX | 39 | $37K |
| Teva Pharmaceuticals USA, Inc. TEVA | 23 | $27K |
| Merz Pharmaceuticals, LLC | 31 | $22K |
| MDD US Operations, LLC | 30 | $15K |
| ACADIA Pharmaceuticals Inc ACAD | 38 | $11K |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 13 | $329 |
| Pfizer Inc. PFE | 12 | $150 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.